Luliyes Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin such as dermatophytosis, tinea corporis, tinea cruris, tinea pedis, and candidiasis. Luliconazole exerts its antifungal effect by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation allows for effective local delivery of the active ingredient, ensuring high tissue concentration at the site of infection with minimal systemic absorption. Luliyes Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, usually for a duration of 1 to 2 weeks depending on the severity and type of infection. It is well tolerated, with adverse effects being uncommon and generally limited to mild local irritation, burning, or itching at the application site. Contraindications include known hypersensitivity to Luliconazole or any excipients in the formulation. Patients should avoid contact with eyes and mucous membranes and discontinue use if severe irritation occurs. Luliyes Cream is a valuable therapeutic option for effective management of superficial fungal infections, promoting rapid symptom relief and resolution.